首页>
外国专利>
PHARMACEUTICAL COMPOSITIONS AND DOSAGE REGIMENS FOR CLINICAL USE OF ANTI-BLOOD DENDRITIC CELL ANTIGEN 2 ANTIBODIES
PHARMACEUTICAL COMPOSITIONS AND DOSAGE REGIMENS FOR CLINICAL USE OF ANTI-BLOOD DENDRITIC CELL ANTIGEN 2 ANTIBODIES
展开▼
机译：抗血树突状细胞抗原2抗体临床应用的药物组合物和剂量方案
展开▼
页面导航
摘要
著录项
相似文献
摘要
Formulations and dosing regimens of anti-blood dendritic cell antigen 2 (BDCA2) antibodies are provided. Such formulations and dosing regimens find use in the treatment of BDCA2-related disorders such as systemic lupus erythematosus, cutaneous lupus erythematosus, and discoid lupus erythematosus, and cytokine release syndrome.
展开▼
